Circulating miR-122 Is a Predictor for Virological Response in CHB Patients With High Viral Load Treated With Nucleos(t)ide Analogs

Chronic hepatitis B (CHB) infection remains worldwide health problem. Antiviral treatment options for CHB patients include nucleos(t)ide analogs (NAs) and interferon. Most of the current biomarkers for predicting treatment response are virus-dependent. MicroRNA-122 is the most abundant liver-specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yin, Gao, Chang, Cai, Shaohang, Xia, Muye, Liao, Guichan, Zhang, Xiaoyong, Peng, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440383/
https://www.ncbi.nlm.nih.gov/pubmed/30967899
http://dx.doi.org/10.3389/fgene.2019.00243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440383/
https://www.ncbi.nlm.nih.gov/pubmed/30967899
http://dx.doi.org/10.3389/fgene.2019.00243

Ejemplares similares